Filip Janku - Chief Medical Officer at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
GLUE on Nasdaq
All Insider Reports
All Insider Reports

Filip Janku - trading volume in the past year for Monte Rosa Therapeutics, Inc.

Holdings reported by Filip Janku for Monte Rosa Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 65,837 $1,283,643 $19.50 23 Feb 2026 Direct
Stock Option (Right to Buy) 139,000 02 Jan 2026 Direct Common Stock

Transactions reported by Filip Janku for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.